Back to all events

AI and Big Data in Longevity Research


Mar 07 2024, Thursday05:00 PM - 08:00 PM (GMT +8:00) Kuala Lumpur, Singapore


32 Carpenter Street, 059911

, Singapore



Join us with a panel of speakers from industry and academia to discover what role AI and big data will play in longevity research.

Artificial intelligence (AI) and big data has given rise to ground-breaking possibilities in healthcare. The transformative potential of AI and big data analytics is reshaping the landscape of medicine, offering new avenues for longevity solutions. Over the past few decades, significant progress has been made in increasing life expectancy worldwide. This upward trend can be attributed to various factors, including advancements in healthcare technologies and access to improved medical treatments. The root causes of aging, however, remain unaddressed while population aging increasingly puts pressure on health care costs. New approaches to this problem are needed. The combination of AI and big data analytics applied to longevity research is one such approach, which promises the discovery of new therapeutics that could have tremendous benefits through the slowing of aging. Join us with the panel of speakers to discover what role AI and big data roles can play in longevity research.

Supporting Image


Date: 07 Mar 2024, Thursday
Time: 5:00 PM - 8:00 PM (GMT +8:00) Kuala Lumpur, Singapore
Location: 32 Carpenter Street, 059911


Moderator's Profile:

Jan Gruber, Scientist, advocate, NUS
Jan Gruber

Prof Jan Gruber is currently an Associate Professor at Yale-NUS. Before his appointment, he was a Senior Research Fellow in the Neurobiology and Ageing Programme at the Centre for Life Sciences (CeLS), National University of Singapore (NUS). He is a physicist-turned-longevity researcher who

Speaker's Profile:

Peter Fedichev, Founder of Gero, Gero
Peter Fedichev

Peter is an entrepreneur and scientist with over 20 years of experience in academic research and biotech business, co-founded three biotech companies: Quantum Pharmaceuticals, a drug discovery company, and Gero, a longevity startup and GlyNeura, a biotech-pharma company aiming to cure Neurodegenerative Diseases.

Speaker's Profile:

Kumar Selvarajoo, Group leader, ASTAR, NTU
Kumar Selvarajoo

Kumar Selvarajoo is a Senior Principal Investigator with the Computational Biology & Omics laboratories at A*STAR’s Bioinformatics Institute (BII) and the Singapore Institute for Food & Biotechnology Innovation (SIFBI), and serves as a National Science Scholarship (BS-PhD) mentor there. He is also an Adjunct Associate Professor at the Yong Loo Lin School of Medicine, National University of Singapore, and the School of Biological Sciences, Nanyang Technological University.

Speaker's Profile:

Kamil Pabis, Researcher and advocate, VitaDAO, NUS
Kamil Pabis

Kamil is a longevity advocate who runs the VitaDAO Aging Science podcast and researchers longevity-promoting compounds at NUS.